FinTechFunding

Actinogen Medical: Files new patent applications

  • Actinogen Medical (ACW) is set to expand its intellectual property portfolio with two new patents
  • The healthcare stock filed the applications for its lead drug candidate, an Alzheimer’s treatment known as Xanamen
  • Positively, the new submissions could extend the drug’s patent life protection up to 2040
  • ACW’s first patent covers a process which seeks to improve cognitive function or treat cognitive decline in healthy adults
  • Meanwhile, the second patent will protect Actinogen’s scale-up manufacturing process
  • Actinogen closed steady following today’s news, with shares worth 2.2 cents each
Previous article
ReadyTech: Completes $25M raise to fund Open Office acquisition
Next article
Mintos: Embarks on crowdfunding camapaing
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Visa and TikTok Launch Creator Card, Enhancing Monetization for Influencers

New financial tool aims to streamline earnings for content creators.Highlights: Visa and TikTok have launched the new Creator...
FinTech

Nium and Coinbase Strengthen Global Stablecoin Settlement Partnership

The collaboration aims to enhance cross-border payments using stablecoins.Highlights: Nium partners with Coinbase to optimize stablecoin settlements.The collaboration...
FinTech

FCA Announces Second Cohort for AI Live Testing Initiative

New phase aims to improve integration of AI in financial services.Highlights: FCA launches second cohort for AI live...
FinTech

Cab Payments Strengthens Case Against Helios Blocking Takeover Bid

Cab Payments contests Helios Investment's actions regarding merger talks.Highlights: Cab Payments accuses Helios of blocking a crucial takeover...